{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:03:01Z","timestamp":1787698981854,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1016\/j.diabres.2005.02.019","type":"journal-article","created":{"date-parts":[[2005,4,16]],"date-time":"2005-04-16T07:28:33Z","timestamp":1113636513000},"page":"13-19","source":"Crossref","is-referenced-by-count":20,"title":["Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment"],"prefix":"10.1016","volume":"70","author":[{"given":"Manuel","family":"P\u00e9rez-Maraver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Mical\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Sahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cayetano","family":"Vinzia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Montanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2005.02.019_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1523-1755.1999.00232.x","article-title":"Renal disease and hypertension in non-insulin dependent diabetes mellitus","volume":"55","author":"Ismail","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabres.2005.02.019_bib2","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1056\/NEJMcp011773","article-title":"Nephropathy in patients with type 2 diabetes","volume":"346","author":"Remuzzi","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diabres.2005.02.019_bib3","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.2337\/diacare.26.7.2150","article-title":"Progression to overt nephropathy in type 2 diabetes","volume":"26","author":"Bruno","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2005.02.019_bib4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s001250050983","article-title":"Renoprotection in diabetes: genetic and non-genetic risk factors and treatment","volume":"41","author":"Parving","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2005.02.019_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study","volume":"353","author":"Gaede","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2005.02.019_bib6","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/diacare.23.10.1478","article-title":"Effect of intensive glycemic control on microalbuminuria in type 2 diabetes","volume":"23","author":"Levin","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2005.02.019_bib7","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/bmj.285.6343.685","article-title":"Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy","volume":"285","author":"Mogensen","year":"1982","journal-title":"Br. Med. J."},{"key":"10.1016\/j.diabres.2005.02.019_bib8","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2337\/diacare.17.2.126","article-title":"Smoking is associated with progression of diabetic nephropathy","volume":"17","author":"Sawicki","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2005.02.019_bib9","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/ki.1997.232","article-title":"The renal risks of smoking","volume":"51","author":"Orth","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabres.2005.02.019_bib10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/ki.1987.50","article-title":"Microalbuminuria as a predictor of clinical diabetic nephropathy","volume":"31","author":"Mogensen","year":"1987","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabres.2005.02.019_bib11","first-page":"19S","article-title":"Renoprotective effects of antihypertensive drugs","volume":"12","author":"Preston","year":"1999","journal-title":"AJH"},{"key":"10.1016\/j.diabres.2005.02.019_bib12","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archinte.155.10.1073","article-title":"Long-term effects of antihypertensive agents on proteinuria and renal function","volume":"155","author":"Maki","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.diabres.2005.02.019_bib13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diabres.2005.02.019_bib14","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diabres.2005.02.019_bib15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.7326\/0003-4819-112-9-707","article-title":"Effects of diltiazem or lisinopril on massive proteinuria associated with diabetes mellitus","volume":"112","author":"Bakris","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.diabres.2005.02.019_bib16","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/ki.1996.480","article-title":"Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy","volume":"50","author":"Bakris","year":"1996","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabres.2005.02.019_bib17","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/ki.1993.171","article-title":"Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria","volume":"43","author":"Brown","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabres.2005.02.019_bib18","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1046\/j.1523-1755.2000.00031.x","article-title":"Renoprotective benefits of RAS inhibition: from ACEI to angiotensinII antagonists","volume":"57","author":"Taal","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabres.2005.02.019_bib19","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/archinte.152.8.1573","article-title":"Calcium antagonists and renal protection. Current status and future perspectives","volume":"152","author":"Epstein","year":"1992","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.diabres.2005.02.019_bib20","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/ki.1992.139","article-title":"Treatment of arterial hypertension in diabetic humans: importance of therapeutic selection","volume":"41","author":"Bakris","year":"1992","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabres.2005.02.019_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/sj.jhh.1000398","article-title":"Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy","volume":"11","author":"Bakris","year":"1997","journal-title":"J. Hum Hypertens"},{"key":"10.1016\/j.diabres.2005.02.019_bib22","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1046\/j.1523-1755.1998.00083.x","article-title":"Effects of an ACE inhibitor\/calcium antagonist combination on proteinuria in diabetic nephropathy","volume":"54","author":"Bakris","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.diabres.2005.02.019_bib23","first-page":"255","article-title":"Early diabetic nephropathy and cardiovascular disease in a mediterranean population: risk factors and treatment intensity","volume":"204","author":"Perez-Maraver","year":"2004","journal-title":"Rev. Clin. Esp."},{"key":"10.1016\/j.diabres.2005.02.019_bib24","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2005.02.019_bib25","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1016\/S0895-7061(99)00111-9","article-title":"Overview of JNC VI: new directions in the management of hypertension and cardiovascular risk","volume":"12","author":"Sheps","year":"1999","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.diabres.2005.02.019_bib26","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S0140-6736(95)91747-0","article-title":"Prevention of diabetic renal disease with special reference to microalbuminuria","volume":"346","author":"Mogensen","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2005.02.019_bib27","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1001\/archinte.157.13.1413","article-title":"The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus","volume":"157","author":"Dinneen","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.diabres.2005.02.019_bib28","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJM199811123392007","article-title":"Patophysiology of progressive nephropathies","volume":"339","author":"Remuzzi","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diabres.2005.02.019_bib29","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"Suppl. 4","key":"10.1016\/j.diabres.2005.02.019_bib30","first-page":"S34","article-title":"ACE inhibition or calcium-channel blockade: renal implications of combination therapy versus a single agent","volume":"28","author":"Kilaru","year":"1996","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.diabres.2005.02.019_bib31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure and risk of macrovascular and microvascular complications in type 2 diabetes. UKPDS 38","volume":"317","year":"1998","journal-title":"Br. Med. J."},{"key":"10.1016\/j.diabres.2005.02.019_bib32","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diabres.2005.02.019_bib33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.7326\/0003-4819-124-7-199604010-00002","article-title":"The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal diseases: a meta-analysis","volume":"124","author":"Pedrini","year":"1996","journal-title":"Ann. Intern. Med."},{"issue":"Suppl. 1","key":"10.1016\/j.diabres.2005.02.019_bib34","first-page":"S33","article-title":"Standards of medical care for patients with diabetes mellitus","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2005.02.019_bib35","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s001250100561","article-title":"Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade","volume":"44","author":"Mifsud","year":"2001","journal-title":"Diabetologia"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822705001014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822705001014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T02:55:22Z","timestamp":1548557722000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822705001014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["S0168822705001014"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2005.02.019","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}